March 2024
1. TANTILLO G, Davis N, Granstein J, Yoo JY, et al
   Provider Experience With the Use of Ketamine for Refractory Status Epilepticus.
   Clin Neuropharmacol. 2024;47:37-43.
   

   >> Share

   
   June 2023
2. ZHAO T, Li HJ, Yu J, Zhang HL, et al
   ABCB1 Gene Polymorphisms Are Closely Associated With Drug-Resistant Epilepsy: Evidence Based on 377 Subjects in Chinese Pediatric Patients.
   Clin Neuropharmacol. 2023 Jun 7. doi: 10.1097/WNF.0000000000000555.
   

   >> Share

   
   May 2023
3. ASADI-POOYA AA
   Precision Medicine in Epilepsy Management; GET Application (Gene, Epilepsy, Treatment).
   Clin Neuropharmacol. 2023;46:95-97.
   

   >> Share

   
   March 2023
4. ASADI-POOYA AA
   Precision Medicine in Epilepsy Management; GET Application (Gene, Epilepsy, Treatment).
   Clin Neuropharmacol. 2023 Mar 31. doi: 10.1097/WNF.0000000000000549.
   

   >> Share

   
   December 2022
5. OTERO TORRES S, Juvany Roig R, Falip Centellas M, Casellas Gibert M, et al
   Therapeutic Drug Monitoring of Lacosamide: Is 10 to 20 mg/L a Suitable Reference Range for Patients With Epilepsy?
   Clin Neuropharmacol. 2022 Dec 27. doi: 10.1097/WNF.0000000000000537.
   

   >> Share

   
   November 2022
6. FARAZDAGHI M, Razavizadegan SMA, Moghimi M, Asadi-Pooya AA, et al
   Efficacy of Valproic Acid Against Coronavirus Disease 2019 Infection or Severity: A Pilot Study.
   Clin Neuropharmacol. 2022;45:175-176.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share